Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
This twice daily injectable established the entire drug class
In a head-to-head study (SURPASS-2), Mounjaro topped Ozempic (1 mg semaglutide), showing it was more effective in helping patients keep their blood sugar levels in check and lose weight
Currently, clinical trials are underway to evaluate the safety and efficacy of tirzepatide in patients with heart failure
however, following Wegovy's 2024 cardiovascular risk reduction indication, Medicare Part D plans may cover Wegovy when prescribed specifically for this cardiovascular indication in eligible patients
Advantages: Gentle: Its not acidic and doesnt sting, so even the most sensitive skin loves it
